Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Alberto Alvarado Miranda"'
Autor:
Alberto Alvarado-Miranda, Fernando Ulises Lara-Medina, Wendy R. Muñoz-Montaño, Juan W. Zinser-Sierra, Paula Anel Cabrera Galeana, Cynthia Villarreal Garza, Daniel Sanchez Benitez, Jesús Alberto Limón Rodríguez, Claudia Haydee Arce Salinas, Alberto Guijosa, Oscar Arrieta
Publikováno v:
Current Oncology, Vol 31, Iss 11, Pp 7177-7179 (2024)
In the original publication [...]
Externí odkaz:
https://doaj.org/article/09becdcb193141bd82046a48236013a3
Autor:
Alberto Alvarado-Miranda, Fernando Ulises Lara-Medina, Wendy R. Muñoz-Montaño, Juan W. Zinser-Sierra, Paula Anel Cabrera Galeana, Cynthia Villarreal Garza, Daniel Sanchez Benitez, Jesús Alberto Limón Rodríguez, Claudia Haydee Arce Salinas, Alberto Guijosa, Oscar Arrieta
Publikováno v:
Current Oncology, Vol 30, Iss 7, Pp 6097-6110 (2023)
(1) Background: recent evidence suggests that long low-dose capecitabine regimens have a synergistic effect with endocrine therapy as aromatase inhibitors (AIs), and might increase overall survival for hormone-receptor-positive, HER2-negative, metast
Externí odkaz:
https://doaj.org/article/41144420c00440e4872eb79005101da1
Autor:
Rafael Vázquez-Romo, Oliver Millan-Catalan, Erika Ruíz-García, Antonio D. Martínez-Gutiérrez, Alberto Alvarado-Miranda, Alma D. Campos-Parra, César López-Camarillo, Nadia Jacobo-Herrera, Eduardo López-Urrutia, Mariano Guardado-Estrada, David Cantú de León, Carlos Pérez-Plasencia
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionMetastatic breast cancer causes the most breast cancer-related deaths around the world, especially in countries where breast cancer is detected late into its development. Genetic testing for cancer susceptibility started with the BRCA 1 a
Externí odkaz:
https://doaj.org/article/97764c68f1a84a5296a92a63cbb25498
Autor:
Alejandro Mohar-Betancourt, Alberto Alvarado-Miranda, Juan Alejandro Torres-Domínguez, Paula Cabrera, Fernando Lara Medina, Yaudim Sadid Villarreal-Gómez, Nancy Reynoso-Noverón
Publikováno v:
Salud Pública de México, Vol 60, Iss 2,mar-abr, Pp 141-150 (2018)
Objective. To evaluate the prognostic factors (clinicalpathological characteristics and treatments) in patients with breast cancer and metastasis to central nervous system (CNS) as the first site of the disease. Materials and methods. Kaplan-Meier me
Externí odkaz:
https://doaj.org/article/c80e5d06386944e6806322e87af914f1
Autor:
Nancy Reynoso-Noverón, Cynthia Villarreal-Garza, Enrique Soto-Perez-de-Celis, Claudia Arce-Salinas, Juan Matus-Santos, María Teresa Ramírez-Ugalde, Alberto Alvarado-Miranda, Paula Cabrera-Galeana, Abelardo Meneses-García, Fernando Lara-Medina, Enrique Bargalló-Rocha, Alejandro Mohar
Publikováno v:
Journal of Global Oncology, Vol 3, Iss 6, Pp 757-764 (2017)
Purpose: One half of the Mexican population lacks comprehensive health care coverage. In 2003, a reform to the General Health Law was approved that led to the creation of the System of Social Protection in Health and made universal health coverage ma
Externí odkaz:
https://doaj.org/article/4528a303bfd54de5b650241497142b31
Autor:
Arrieta, Alberto Alvarado-Miranda, Fernando Ulises Lara-Medina, Wendy R. Muñoz-Montaño, Juan W. Zinser-Sierra, Paula Anel Cabrera Galeana, Cynthia Villarreal Garza, Daniel Sanchez Benitez, Jesús Alberto Limón Rodríguez, Claudia Haydee Arce Salinas, Alberto Guijosa, Oscar
Publikováno v:
Current Oncology; Volume 30; Issue 7; Pages: 6097-6110
(1) Background: recent evidence suggests that long low-dose capecitabine regimens have a synergistic effect with endocrine therapy as aromatase inhibitors (AIs), and might increase overall survival for hormone-receptor-positive, HER2-negative, metast
Autor:
Raúl García-Vazquez, Erika Ruiz-García, Abelardo Meneses García, Horacio Astudillo-de la Vega, Fernando Lara-Medina, Alberto Alvarado-Miranda, Héctor Maldonado-Martínez, Juan A González-Barrios, Alma D Campos-Parra, Sergio Rodríguez Cuevas, Laurence A Marchat, César López-Camarillo
Publikováno v:
Tumor Biology, Vol 39 (2017)
Neoadjuvant chemotherapy aims to improve the outcome of breast cancer patients, but only few would benefit from this treatment. Pathological complete response has been proposed as a surrogate marker for the prediction of long-term clinical benefits;
Externí odkaz:
https://doaj.org/article/f70a8a466f5543a9868f5afa6fafadf9
Autor:
Lenny Gallardo, Germán Calderillo-Ruiz, Paula Cabrera-Galeana, Rafael Rodríguez-Ortiz, Alberto Alvarado-Miranda, Karla Itzel Aguilar-Flores
Publikováno v:
Gaceta Mexicana de Oncolog�a. 18
Autor:
Antelmo Abelardo Meneses-García, Bernardo Cacho-Díaz, Alberto Alvarado-Miranda, Laura G. Mendoza-Olivas, Cynthia Villarreal-Garza, Karen Salmerón-Moreno, Mariana Chavez-MacGregor, Alejandra Alvarez-Alvarez, Nancy Reynoso-Noverón
Publikováno v:
Cancer. 126:3456-3463
BACKGROUND The current study was performed to identify factors that are present at the time of breast cancer (BC) diagnosis that are associated with a higher rate of central nervous system metastasis (CNSm). METHODS The authors analyzed a database of
Autor:
Paula Cabrera-Galeana, O Arrieta-Rodriguez, C Gamboa, Alberto Alvarado-Miranda, Enrique Bargallo-Rocha, F Porras-Reyes, Fernando Lara-Medina, Wendy Muñoz-Montaño, M Perez, Alejandro Mohar-Betancourt
Publikováno v:
Cancer Research. 79:P1-19
Background: CNS metastases are reported in about 10 to 15%. Knowledge about the management of these patients are limited because they are excluded from clinical trials due to its poor prognosis and morbidity. In these study, we aim to describe charac